Multi-Omics Augmented Intelligence for T-cell Therapy Drug Discovery and Development11-50 Employees

ImmunoMind careers

Multi-Omics Augmented Intelligence for T-cell Therapy Drug Discovery and Development

ImmunoMind improves the design of T-cell therapies by precisely identifying T-cell subpopulations and their immune profile. ImmunoMind’s Augmented Intelligence platform guides translational and clinical research to improve the product’s quality, safety and efficacy with single-cell precision. The platform is based on proprietary single-cell multi-omics technologies to automatically evaluate cell differentiation, estimate exhaustion rate of subpopulations and identify off-tumor targets.
UC Berkeley SkyDeck’20 Alumnus.

Jobs